Gene · 51327
AHSP: alpha hemoglobin stabilizing protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AHSP: alpha hemoglobin stabilizing protein. Genes, record 51327. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51327
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NZD4 | Alpha-hemoglobin-stabilizing protein | 102 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents20
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37145 | Q9NZD4 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4228 | Q9NZD4 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 4228 | Q9NZD4 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 107199 | Q9NZD4 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 217580 | Q9NZD4 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 217580 | Q9NZD4 | Espacenet |
| JP 2015516143 A | 2015-06-08 | 217580 | Q9NZD4 | Espacenet |
| US 8586006 B2 | 2013-11-19 | 2191 | Q9NZD4 | Espacenet |
| JP 2010500568 A | 2010-01-07 | 32277 | Q9NZD4 | Espacenet |
| EP 2057465 A2 | 2009-05-13 | 2191 | Q9NZD4 | Espacenet |
1 to 10 of 20
See all 20 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants726
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AHSP papers | Newest fiscal year |
|---|---|---|---|
| P01CA108671 | Myeloproliferative Neoplasms-Research Consortium | 3 | 2025 |
| R01HL098032 | Omics, mice and men: Development of precision transfusion medicine | 3 | 2025 |
| R01HL119479 | Regulation of Hemoglobin Switching | 3 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 2 | 2025 |
| P30ES005022 | Rutgers Center for Environmental Exposure and Disease (CEED) | 2 | 2025 |
| R01CA194496 | Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands | 2 | 2025 |
| R01DK119506 | Novel Regulation of Renal Function by S-Nitrosylation | 2 | 2025 |
| R01HL122010 | Decrypting Variants of Uncertain Significance in Long-QT Syndrome | 2 | 2025 |
| R01HL126900 | Restoration and Function of S-Nitrosothiol in Stored Blood | 2 | 2025 |
| R01HL156647 | Base editing and prime editing for sickle cell disease | 2 | 2025 |
1 to 10 of 726Source NIH's project files
See all 726 nih grantsPapers1,546
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteomics identifies potential biomarkers of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. | J Clin Neurosci | 2026 | 42322686 | PubTator, text mining | PubMed |
| Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction? | Eur Heart J Cardiovasc Pharmacother | 2026 | 42213452 | PubTator, text mining | PubMed |
| Correction: AHSP as a novel non-invasive urinary biomarker for prostate cancer. | BMC Cancer | 2026 | 42210155 | PubTator, text mining | PubMed |
| Genetically prioritized plasma proteins in intracerebral hemorrhage identified by Mendelian randomization with functional evidence of neuronal vulnerability. | Am J Transl Res | 2026 | 42170445 | PubTator, text mining | PubMed |
| Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia. | Ann Hematol | 2026 | 41902926 | PubTator, text mining | PubMed |
| Hb Thessaloniki, a Novel, Hyperunstable, Alpha Globin Variant Detected in Northern Greece. | Hematol Rep | 2026 | 41874100 | PubTator, text mining | PubMed |
| Association of gender and main comorbidities with expression of lncRNAs and mRNAs in COVID-19 patients. | J Genet Eng Biotechnol | 2026 | 41839673 | PubTator, text mining | PubMed |
| Exploring biomarkers associated with tetraspanins in sepsis: a comprehensive analysis of transcriptome consortium experimental validation. | Shock | 2026 | 41811169 | PubTator, text mining | PubMed |
| AHSP as a novel non-invasive urinary biomarker for prostate cancer. | BMC Cancer | 2026 | 41761114 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Mechanisms in Serrated Adenocarcinomas and Classical Colorectal Carcinomas: An In Silico Study. | Curr Issues Mol Biol | 2026 | 41751442 | PubTator, text mining | PubMed |
1 to 10 of 1,546
See all 1,546 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51327
GET https://conductscience.org/api/genes/v1/51327/patents